Cargando…
Aspirin for primary prevention of cardiovascular disease: Advice for a decisional strategy based on risk stratification
The need for aspirin therapy as part of primary prevention of cardiovascular (CV) disease is currently being highly debated, especially after 3 studies in different settings reported that a reduction in ischemic events is largely counterbalanced by an increase in bleeding events. One possible explan...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Kare Publishing
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7040875/ https://www.ncbi.nlm.nih.gov/pubmed/32011329 http://dx.doi.org/10.14744/AnatolJCardiol.2019.89916 |